New York Legislature Passes Medical Marihuana Law


Subject to signature by Governor Andrew Cuomo, New York is set to become the twenty-third state to legalize medical marihuana. Importantly, the New York legislation is limited to non-smokable forms of marihuana. Further, the bill is initially limited to persons with the following “severe debilitating or life-threatening conditions”: cancer, HIV or AIDS, ALS, Parkinson’s disease, multiple sclerosis, spinal cord damage, epilepsy, inflammatory bowel disease, neuropathies, and Huntington’s disease. The New York Commissioner of Health is authorized to consider and add additional conditions to this list. The new law, if passed, also may be suspended or terminated by the governor at any time, and it is subject to a seven-year sunset provision.

Of importance to New York employers, the legislation specifically states that being a “certified patient” with any covered condition automatically deems an employee to be “disabled” under the New York State Human Rights Law. However, the bill expressly permits employers to enforce a policy prohibiting employees from performing their job duties while impaired by a controlled substance. Further, the bill does not require that employers violate federal law or do anything to cause the loss of a federal contract or funding.

Governor Cuomo supported the final version of the legislation and he is expected to sign it into law. Prior to the law becoming effective, we advise New York employers to review their existing workplace policies and consider expressly prohibiting the use of controlled substances in the workplace. Further, New York employers should be aware that employees who meet the approved conditions to use medical marihuana are per se deemed disabled. Employers may therefore want to carefully consider their response to any disability accommodation requests from covered employees. 

Note: This article was published in the June 30, 2014 issue of the New York eAuthority.

Written by:

Published In:

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Ogletree, Deakins, Nash, Smoak & Stewart, P.C. | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »

All the intelligence you need, in one easy email:

Great! Your first step to building an email digest of JD Supra authors and topics. Log in with LinkedIn so we can start sending your digest...

Sign up for your custom alerts now, using LinkedIn ›

* With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name.